For the treatment groups with CuCl 2 and Cu(OAc) 2 , copper compounds had a positive correlation with the protein level regulated
If you want a broader look at how these medications fit into treatment decisions, our GLP-1 medication safety guide is a helpful place to start
The Ingredients
These may include nausea, decreased appetite, vomiting, constipation, diarrhea, bloating, or abdominal discomfort
Your doctor may adjust the dosage, recommend lifestyle changes, or check if other health conditions are affecting your progress
If the FDA approves adding these peptides to the list, compounding pharmacies could use them to make customized medications for patients